[HTML][HTML] Pharmacological treatment of COVID-19: an opinion paper
A García-Lledó, J Gómez-Pavón… - Revista Española …, 2021 - pmc.ncbi.nlm.nih.gov
The precocity and efficacy of the vaccines developed so far against COVID-19 has been the
most significant and saving advance against the pandemic. The development of vaccines …
most significant and saving advance against the pandemic. The development of vaccines …
A comprehensive review on potential therapeutics interventions for COVID-19
COVID-19 is an infectious respiratory disease caused by SARS-CoV-2, a new beta
coronavirus that emerged in Wuhan, China. Being primarily a respiratory disease, it is highly …
coronavirus that emerged in Wuhan, China. Being primarily a respiratory disease, it is highly …
COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials
R Chakraborty, S Parvez - Biochemical pharmacology, 2020 - Elsevier
COVID-19, the greatest public health emergency of the 21st century, has affected 215
countries and territories around the world resulting in 15,151,738 confirmed cases and …
countries and territories around the world resulting in 15,151,738 confirmed cases and …
Therapeutic strategies to fight COVID‐19: Which is the status artis?
C Scavone, A Mascolo, C Rafaniello… - British Journal of …, 2022 - Wiley Online Library
COVID‐19 is a complex disease, and many difficulties are faced today especially in the
proper choice of pharmacological treatments. The role of antiviral agents for COVID‐19 is …
proper choice of pharmacological treatments. The role of antiviral agents for COVID‐19 is …
SARS-CoV-2: immune response elicited by infection and development of vaccines and treatments
G Canedo-Marroquin, F Saavedra… - Frontiers in …, 2020 - frontiersin.org
The World Health Organization (WHO) announced in March a pandemic caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …
[HTML][HTML] Vacuna frente al COVID-19
JJ Picazo - Revista Española de Quimioterapia, 2021 - ncbi.nlm.nih.gov
La pandemia por COVID-19 ha producido en nuestra sociedad un colapso sanitario,
económico y psicológico enorme. Los sanitarios han tenido que enfrentarse a uno de los …
económico y psicológico enorme. Los sanitarios han tenido que enfrentarse a uno de los …
A global picture: therapeutic perspectives for COVID-19
VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
Current pharmacological treatments for COVID‐19: What's next?
C Scavone, S Brusco, M Bertini… - British journal of …, 2020 - Wiley Online Library
Since December 2019 SARS‐Cov‐2 was found responsible for the disease COVID‐19,
which has spread worldwide. No specific therapies/vaccines are yet available for the …
which has spread worldwide. No specific therapies/vaccines are yet available for the …
Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
The possible of immunotherapy for COVID-19: A systematic review
A AminJafari, S Ghasemi - International immunopharmacology, 2020 - Elsevier
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …
described in late December 2019 and causes a severe respiratory infection in humans …